Condition
Dystonia, Secondary
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 1 (2)
Trial Status
Recruiting2
Not Yet Recruiting1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06554288Phase 1Recruiting
Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy
NCT03428009Recruiting
Dystonia Genotype-Phenotype Correlation
NCT05612464Not Yet Recruiting
Enhancing Sensorimotor Processing in Children With Dystonia
NCT02982304Phase 1Unknown
Multi-Target Pallidal and Thalamic Deep Brain Stimulation for Hemi-Dystonia
Showing all 4 trials